ReviewJournal for immunotherapy of cancer2020
Tim-3 finds its place in the cancer immunotherapy landscape.
Nandini Acharya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
258 papers cite itlatest 60 shown
this paperpooled ittrialcites it